A Trial of Rehabilitation Therapy in Older Acute Heart Failure Patients
Completed · Not applicable
Conditions studied: Acute Decompensated Heart Failure
In brief
REHAB-HF: A Trial of Rehabilitation Therapy in Older Acute Heart Failure Patients, is a multicenter, randomized, attention-controlled, single-blind trial designed to examine the hypothesis that, in addition to standard care, a novel, tailored, progressive, multi-domain rehabilitation intervention administered to older patients with acute decompensated heart failure (ADHF) beginning early during hospitalization and continuing for 12 weeks will improve physical function and key clinical outcomes, including the rate of rehospitalization.
Key facts
- Study ID
- NCT02196038
- Run by
- Wake Forest University Health Sciences
- People needed
- 349
- Starts
- 2014-09-01
- Expected to finish
- 2020-07-27
- Last updated by the study team
- 2021-06-24
Who can join
Age: 60 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age ≥ 60 years old
- In the hospital setting >24 hours for the management of ADHF, or diagnosed with ADHF after being hospitalized for another reason. ADHF will be confirmed by the study physician, and will be defined according to the Food and Drug Administration definition of hospitalized heart failure as a combination of symptoms, signs, and HF-specific medical treatments.
You may not qualify if…
- Acute myocardial infarction
- Planned discharge other than to home or a facility where the participant will live independently
- Already actively participating in formal, facility-based cardiac rehabilitation
Where it is running
- Duke University Medical Center — Durham, North Carolina, United States
- Wake Forest Baptist Health — Winston-Salem, North Carolina, United States
- Thomas Jefferson University and Hospital — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.